Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9354034 | Journal of Orthopaedic Research | 2005 | 7 Pages |
Abstract
The purpose of this work is to demonstrate the feasibility of T1Ï-weighted magnetic resonance imaging (MRI) to quantitatively measure changes in proteoglycan content in cartilage. The T1Ï MRI technique was implemented in an in vivo porcine animal model with rapidly induced cytokine-mediated cartilage degeneration. Six pigs were given an intra-articular injection of recombinant porcine interleukin-1β (IL-1β) into the knee joint before imaging to induce changes in cartilage via matrix metalloproteinase (MMP) induction. The induction of MMPs by IL-1 was used since it has been extensively studied in many systems and is known to create conditions that mimic in part characteristics similar to those of osteoarthritis. The contralateral knee joint was given a saline injection to serve as an internal control. T1Ï-weighted MRI was performed on a 4 T whole-body clinical scanner employing a 2D fast spin-echo-based T1Ï imaging sequence. T1Ï relaxation parameter maps were computed from the T1Ï-weighted image series. The average T1Ï relaxation rate, R1Ï (1/T1Ï) of the IL-1β-treated patellae was measured to be on average 25% lower than that of saline-injected patellae indicating a loss of proteoglycan. There was an average reduction of 49% in fixed charge density, measured via sodium MRI, of the IL-1β-treated patellae relative to control corroborating the loss of proteoglycan. The effects of IL-1β, primarily loss of PG, were confirmed by histological and immunochemical findings. The results from this study demonstrate that R1Ï is able to track proteoglycan content in vivo.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Andrew J. Wheaton, George R. Dodge, Arijitt Borthakur, J. Bruce Kneeland, H. Ralph Schumacher, Ravinder Reddy,